US 12414934
Combination therapies
granted A61KA61K2300/00A61K31/353
Quick answer
US patent 12414934 (Combination therapies) held by Aardvark Therapeutics, Inc. expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aardvark Therapeutics, Inc.
- Grant date
- Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2300/00, A61K31/353, A61K31/404, A61K31/44